IL-6-mediated events in Alzheimer's disease pathology
- 30 November 1991
- journal article
- other
- Published by Elsevier in Immunology Today
- Vol. 12 (11), 422
- https://doi.org/10.1016/0167-5699(91)90148-m
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease corticesFEBS Letters, 1991
- Interleukin-6 in clinical medicineAnnals of Hematology, 1991
- Alzheimer's disease amyloid β-clipping enzyme (APP secretase): Identification, purification, and characterization of the enzymeBiochemical and Biophysical Research Communications, 1991
- In-vitro matured human macrophages express Alzheimer's βA4-amyloid precursor protein indicating synthesis in microglial cellsFEBS Letters, 1991
- Alpha 2‐macroglobulin synthesis in interleukin‐6‐stimulated human neuronal (SH‐SY5Y neuroblastoma) cells Potential significance for the processing of Alzheimer β‐amyloid precursor proteinFEBS Letters, 1991
- Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes.The Journal of Experimental Medicine, 1989
- Alzheimer's disease antibodies bind specifically to a neurofilament protein in Torpedo cholinergic neuronsJournal of Neuroscience, 1989
- Interleukin-6 and its receptor during homeostasis, inflammation, and tumor growthKlinische Wochenschrift, 1989
- Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophagesBlood, 1988
- α2‐Macroglobulin Synthesis in an Astrocyte SubpopulationJournal of Neurochemistry, 1987